PRINCETON, N.J., March 30 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, today announced that it will not issue its fourth quarter and full year 2005 financial results on March 30, 2006 as previously announced due to a delay it is experiencing in the completion of the audit of its 2005 consolidated financial statements and the amount of internal and external audit work needed to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002. The company and its auditors are working diligently to complete the audit and the company intends to announce a new date for the release of its fourth quarter and full year 2005 financial results as soon as possible.
About Orchid Cellmark
Orchid Cellmark is a leading provider of identity DNA testing services for the human identity and agriculture markets. In the human identity area, the company provides DNA testing services for forensic, family relationship and security applications. In the agriculture field, Orchid Cellmark provides DNA testing services for selective trait breeding. Orchid Cellmark’s strong market positions in these segments reflect the company’s accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark brand that has been associated with exceptional quality, reliability and customer service for nearly two decades. More information on Orchid Cellmark can be found at http://www.orchid.com .
Orchid Cellmark Inc.
CONTACT: Tracy J. Henrikson, Executive Director, Corporate Communicationsof Orchid Cellmark Inc., +1-609-750-2221
Web site: http://www.orchid.com/
